 Currently psychiatric diagnoses are solely based on clinical psychopathological criteria , and do not involve objective biological markers. However , a wealth of neuropsychiatric research supports , that schizophrenia is both clinically and biologically a heterogeneous syndrome<disease><symptom>. Perspectives for neurobiological subgrouping of patients with schizophrenia , targeted treatment regimens as well as clarification of early causal risk factors envision , that in the coming years objective neuropsychiatric paradigms will be implemented in clinical practice.